Cargando…
The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction
Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Despite the progress in the treatment of AMI, streptokinase is still being used in many countries. Because of the critical condition of patients with AMI and complications of streptokinase therapy, this s...
Autores principales: | Aslanabadi, Naser, Safaie, Naser, Talebi, Fereshteh, Dousti, Samaneh, Entezari-Maleki, Taher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958324/ https://www.ncbi.nlm.nih.gov/pubmed/29796029 |
Ejemplares similares
-
The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population
por: Aslanabadi, Naser, et al.
Publicado: (2015) -
Vitamin D Deficiency Predicts the ST Elevation Type of Myocardial Infarction in Patients with Acute Coronary Syndrome
por: Safaie, Naser, et al.
Publicado: (2018) -
Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital
por: Bawaskar, Himmatrao S., et al.
Publicado: (2019) -
Reteplase versus Streptokinase in Management of ST-segment Elevation Myocardial Infarction; a Letter to the Editor
por: Giahchi, Fahimeh, et al.
Publicado: (2019) -
Association of admission testosterone level with ST-segment resolution in male patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Separham, Ahmad, et al.
Publicado: (2017)